The Fly | SMPNY

Today

Great Southern Bancorp reports preliminary Q2 EPS $1.43, consensus $1.38

GSBC

5:22 PM

Wolfe cuts Ionis Pharma to Peer Perform after disappointing trial data

5:20 PM

Matson sees Q2 EPS $4.12-$4.30, consensus $3.79

MATX

5:19 PM

Intellia Therapeutics just downgraded at Wolfe Research, here's why

NTLA

5:18 PM

Home BancShares reports Q2 adjusted EPS 64c, consensus 61c

HOMB

5:16 PM

UroGen Pharma price target raised by $26 at Goldman Sachs, here's why

URGN

5:14 PM

Wolfe Research gets more bearish on Ionis Pharmaceuticals, downgrades shares

IONS

5:11 PM

UroGen Pharma gets new US patent allowance into July 2044 for ZUSDURI, UGN-103

URGN

5:08 PM

Fury Gold Mines suspends activities at Eau Claire camp due to forest fire

FURY

5:03 PM

ArrowMark Financial Corp. reports estimated NAV $21.00 as of June 30

BANX

5:02 PM

Cboe data shows mixed options sentiment in TeraWulf with shareslittle changed

WULF

4:59 PM

Telesat initiated with bullish view at Stifel, here's why

TSAT

4:54 PM

Arm transferred with Hold rating at Benchmark

4:49 PM

NextDecade initiated with neutral view at Goldman Sachs, here's why

4:47 PM

Synopsys initiated with bullish view at Benchmark, here's why

SNPS

4:46 PM

Ceva initiated with neutral view at Benchmark, here's why

CEVA

4:45 PM

Rambus initiated with bullish view at Benchmark, here's why

RMBS

4:44 PM

Excelerate Energy initiated with bullish view at Goldman Sachs, here's why

4:43 PM

Cboe data shows mixed options sentiment in Marvell with shares down 7.22%

MRVL

4:43 PM

Cadence Design initiated with bullish view at Benchmark, here's why

CDNS

4:43 PM

Cantor software analysts hold an analyst/industry conference call

4:42 PM

Quebecor initiated with neutral view at Raymond James, here's why

QBCRF

4:37 PM

BCE initiated with neutral view at Raymond James, here's why

4:36 PM

The Hanover CEO John Roche to retire at 2026-end

4:36 PM

Telus initiated with neutral view at Raymond James, here's why

4:34 PM

Charts

Today

Great Southern Bancorp reports preliminary Q2 EPS $1.43, consensus $1.38

GSBC

5:22 PM

Wolfe cuts Ionis Pharma to Peer Perform after disappointing trial data

5:20 PM

Matson sees Q2 EPS $4.12-$4.30, consensus $3.79

MATX

5:19 PM

Intellia Therapeutics just downgraded at Wolfe Research, here's why

NTLA

5:18 PM

Home BancShares reports Q2 adjusted EPS 64c, consensus 61c

HOMB

5:16 PM

UroGen Pharma price target raised by $26 at Goldman Sachs, here's why

URGN

5:14 PM

Wolfe Research gets more bearish on Ionis Pharmaceuticals, downgrades shares

IONS

5:11 PM

UroGen Pharma gets new US patent allowance into July 2044 for ZUSDURI, UGN-103

URGN

5:08 PM

Fury Gold Mines suspends activities at Eau Claire camp due to forest fire

FURY

5:03 PM

ArrowMark Financial Corp. reports estimated NAV $21.00 as of June 30

BANX

5:02 PM

Cboe data shows mixed options sentiment in TeraWulf with shareslittle changed

WULF

4:59 PM

Telesat initiated with bullish view at Stifel, here's why

TSAT

4:54 PM

Arm transferred with Hold rating at Benchmark

4:49 PM

NextDecade initiated with neutral view at Goldman Sachs, here's why

4:47 PM

Synopsys initiated with bullish view at Benchmark, here's why

SNPS

4:46 PM

Ceva initiated with neutral view at Benchmark, here's why

CEVA

4:45 PM

Rambus initiated with bullish view at Benchmark, here's why

RMBS

4:44 PM

Excelerate Energy initiated with bullish view at Goldman Sachs, here's why

4:43 PM

Cboe data shows mixed options sentiment in Marvell with shares down 7.22%

MRVL

4:43 PM

Cadence Design initiated with bullish view at Benchmark, here's why

CDNS

4:43 PM

Cantor software analysts hold an analyst/industry conference call

4:42 PM

Quebecor initiated with neutral view at Raymond James, here's why

QBCRF

4:37 PM

BCE initiated with neutral view at Raymond James, here's why

4:36 PM

The Hanover CEO John Roche to retire at 2026-end

4:36 PM

Telus initiated with neutral view at Raymond James, here's why

4:34 PM

Company News

Charts

Company News

Charts